about
A comprehensive pathway map of epidermal growth factor receptor signalingPlexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformationThe ErbB signaling network: receptor heterodimerization in development and cancerYB-1 drives preneoplastic progression: Insight into opportunities for cancer preventionEGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infectionPolyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells.Molecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast CancerEfficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members.HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer.eps15, a novel tyrosine kinase substrate, exhibits transforming activity.Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion.HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer.Changes in mammary caveolin-1 signaling pathways are associated with breast cancer risk in rats exposed to estradiol in utero or during prepubertyCarboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product.Role of ErbB2 in Corneal Epithelial Wound Healing.Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor.The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer.A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway.Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells.The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain.Eosinophil peroxidase activates cells by HER2 receptor engagement and β1-integrin clustering with downstream MAPK cell signaling.EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity.Signaling by ERBB4Trans-autophosphorylation of ERBB2 heterodimersThe Complex Subtype-Dependent Role of Connexin 43 (GJA1) in Breast Cancer.
P2860
Q24672490-4B03C765-FCBF-45F8-AA38-F23F9AB8FFEDQ24676439-865880EA-7185-45EC-8DDB-165D4DB9AB9EQ28577281-FBFA91C0-DEDA-4BAD-8BA9-86484951FF5BQ29617919-48DB3788-C632-4640-A6F9-B500D29CB36AQ35640233-0643DCB9-ADF0-4253-B914-D0D58E320622Q36212929-03E2B064-FFFB-41F5-9762-C371C8E872BCQ36245418-D51EC5DB-476E-48E9-A74A-D92C2EB4ACC1Q36440214-312CE418-E0F3-44C4-8B29-52985B3D47A2Q36643816-7AF8DB35-CA03-4E63-960C-7DA9FEFB57CBQ36698389-F981B6E2-408E-4B20-A7A3-4EBC8DCCD439Q36701817-787A3D72-B5F8-41AA-91AE-5A7997F354C1Q36710875-0AC5B3C7-2BCF-48FC-98E5-AD8BC2FB565AQ36751137-74296CAD-CFF1-4F79-8190-C15DE1063391Q36950653-78B63CD7-88A2-4E3E-9750-47BCB8934DAEQ37146015-A354673C-068B-4C27-B120-1323EEEB2154Q37152335-BBA38D52-D057-48CA-854F-52BCB24C488EQ37280359-87C6D4C8-9686-4F59-BB66-2E2FC7021F83Q37333311-3959DA17-FD43-4F1D-8370-D33CF5A32638Q37630052-361177D8-5958-478B-97FE-AB11F9181DE1Q37634563-19366723-C210-4898-A8C8-485CCB5400F6Q37801469-C29A34B4-A3A0-47BC-B63F-739D1ED48250Q38336919-328C5E83-E981-43AD-B9B6-16C66C494F19Q38752227-2A4FA01A-3CF8-4CC7-A883-EE697330387CQ40678332-D26310FA-6F3B-41D0-8E3B-107A2F5F676CQ45318103-A521A5FC-F42F-4EA2-B13F-DB91624095F7Q50297989-3B1CAF16-8FCD-4557-8ED1-8F5D2E5510E8Q52370671-75FE15E2-AB64-472A-A21A-DC20C52DEAA6
P2860
description
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1990
@ast
scientific journal article
@en
vedecký článok (publikovaný 1990/01/01)
@sk
vědecký článek publikovaný v roce 1990
@cs
wetenschappelijk artikel (gepubliceerd op 1990/01/01)
@nl
wissenschaftlicher Artikel
@de
наукова стаття, опублікована в січні 1990
@uk
مقالة علمية (نشرت عام 1990)
@ar
name
Identification of autophosphorylation sites of HER2/neu
@ast
Identification of autophosphorylation sites of HER2/neu
@en
Identification of autophosphorylation sites of HER2/neu
@nl
type
label
Identification of autophosphorylation sites of HER2/neu
@ast
Identification of autophosphorylation sites of HER2/neu
@en
Identification of autophosphorylation sites of HER2/neu
@nl
prefLabel
Identification of autophosphorylation sites of HER2/neu
@ast
Identification of autophosphorylation sites of HER2/neu
@en
Identification of autophosphorylation sites of HER2/neu
@nl
P2093
P3181
P1476
Identification of autophosphorylation sites of HER2/neu
@en
P2093
A. Ullrich
A. Zilberstein
B. Margolis
J. Schlessinger
M. Dombalagian
P3181
P577
1990-01-01T00:00:00Z